Consecutive quantitative cytology in bladder cancer

Urology

Volumn 56, Issue 4, 2000, Pages 584-588

  Van Der Poel, H G ^c   Van Rhijn, B W G ^a   Peelen, P ^a   Debruyne, F M J ^a   Boon, M E ^b   Schalken, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MITOMYCIN;

ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CANCER CYTODIAGNOSIS; CANCER INVASION; CANCER STAGING; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SAMPLE; SUPERFICIAL CANCER; TUMOR RECURRENCE;

AGED; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0033830126     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00726-3     Document Type: Article

References (13)

1. Kamat A.M., Lamm D.L. Intravesical therapy for bladder cancer. Urology. 55:2000;161-168.
2. Leblanc B., Duclos A.J., Bénard F., et al. Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol. 162:1999;1946-1950.
3. Wiener H.G., Mian C., Haitel A., et al. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol. 159:1998;1876-1880.
4. Witjes J.A., van der Poel H.G., van Balken M.R., et al. Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer. Eur Urol. 33:1998;387-391.
5. van der Poel H.G., van Balken M.R., Schamhart D.H., et al. Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer. Urology. 51:1998;44-50.
6. Loh C.S., Spedding A.V., Ashworth M.T., et al. The value of exfoliative urine cytology in combination with flexible cystoscopy in the diagnosis of recurrent transitional cell carcinoma of the urinary bladder. Br J Urol. 77:1996;655-658.
7. van der Poel H.G. Markers for recurrence of superficial bladder cancer what is valid? Curr Opin Urol. 9:1999;401-406.
8. van der Poel H.G., Witjes J.A., van Stratum P., et al. Quanticyt karyometric analysis of bladder washing for patients with superficial bladder cancer . Urology. 48:1996;357-364.
9. van der Poel H.G., Boon M.E., van Stratum P., et al. Conventional bladder wash cytology performed by four experts versus quantitative image analysis. Mod Pathol. 10:1997;976-982.
10. Boon M.E., Marres E.M., van der Poel H.G. Combining QUANTICYT karyometric analysis with architectural confocal-aided cytology to prognosticate superficial bladder cancer. Diagn Cytopathol. 18:1998;10-17.
11. Sherman A.B., Koss L.G., Adams S.E. Interobserver and intraobserver differences in the diagnosis of urothelial cells comparison with classification by computer . Anal Quant Cytol. 6:1984;112-118.
12. Malik S.N., Murphy W.M. Monitoring patients for bladder neoplasms what can be expected of urinary cytology consultations in clinical practice . Urology. 54:1999;62-66.
13. Fujii Y., Fukui I., Kihara K., et al. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 36:1999;309-313.